New drug trial aims to shrink tumors before surgery
NCT ID NCT07489066
Summary
This study is testing a new medicine called PF-08634404 for adults with early-stage or locally advanced non-small cell lung cancer. Researchers want to see if the drug works better when given alone or with chemotherapy, either before surgery or after other treatments. The trial will measure how well tumors respond, safety, and whether the treatment helps prevent cancer from returning.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.